Invention Grant
- Patent Title: Method of treating hemophilia A
-
Application No.: US16031503Application Date: 2018-07-10
-
Publication No.: US10792336B2Publication Date: 2020-10-06
- Inventor: Amit Nathwani , Jenny McIntosh , Edward Tuddenham , Andrew Davidoff
- Applicant: UCL BUSINESS PLC , ST. JUDE CHILDREN'S RESEARCH HOSPITAL
- Applicant Address: US TN Memphis GB London
- Assignee: ST. JUDE CHILDREN'S RESEARCH HOSPITAL,UCL BUSINESS LTD
- Current Assignee: ST. JUDE CHILDREN'S RESEARCH HOSPITAL,UCL BUSINESS LTD
- Current Assignee Address: US TN Memphis GB London
- Agency: Marshall, Gerstein & Borun LLP
- Priority: com.zzzhc.datahub.patent.etl.us.BibliographicData$PriorityClaim@323cebde
- Main IPC: C12N1/00
- IPC: C12N1/00 ; A61K38/37 ; C07K14/755 ; A01K67/027 ; A61K48/00

Abstract:
There is provided a nucleic acid molecule comprising a nucleotide sequence encoding a Factor VIII protein, wherein a B domain portion of the Factor VIII protein is encoded by a nucleotide sequence between 90 and 111 nucleotides in length and has an amino acid sequence that is at least 85% identical to SEQ ID NO: 4 which comprises six asparagine residues. Also provided is a Factor VIII protein, a vector comprising the above nucleic acid molecule, a host cell, a transgenic animal, a method of treating Haemophilia Haemophilia A, and a method for the preparation of a parvoviral gene delivery vector.
Public/Granted literature
- US20180311317A1 Factor VIII Sequences Public/Granted day:2018-11-01
Information query